1. Home
  2. CCEL vs PYPD Comparison

CCEL vs PYPD Comparison

Compare CCEL & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCEL
  • PYPD
  • Stock Information
  • Founded
  • CCEL 1989
  • PYPD 2008
  • Country
  • CCEL United States
  • PYPD Israel
  • Employees
  • CCEL N/A
  • PYPD N/A
  • Industry
  • CCEL Managed Health Care
  • PYPD Medical/Dental Instruments
  • Sector
  • CCEL Health Care
  • PYPD Health Care
  • Exchange
  • CCEL Nasdaq
  • PYPD Nasdaq
  • Market Cap
  • CCEL 39.9M
  • PYPD 36.0M
  • IPO Year
  • CCEL 1997
  • PYPD 2020
  • Fundamental
  • Price
  • CCEL $4.89
  • PYPD $3.49
  • Analyst Decision
  • CCEL Strong Buy
  • PYPD Strong Buy
  • Analyst Count
  • CCEL 1
  • PYPD 5
  • Target Price
  • CCEL $8.50
  • PYPD $11.40
  • AVG Volume (30 Days)
  • CCEL 13.3K
  • PYPD 1.4M
  • Earning Date
  • CCEL 07-14-2025
  • PYPD 08-13-2025
  • Dividend Yield
  • CCEL 19.76%
  • PYPD N/A
  • EPS Growth
  • CCEL N/A
  • PYPD N/A
  • EPS
  • CCEL 0.01
  • PYPD N/A
  • Revenue
  • CCEL $32,102,750.00
  • PYPD N/A
  • Revenue This Year
  • CCEL $2.49
  • PYPD N/A
  • Revenue Next Year
  • CCEL $0.95
  • PYPD N/A
  • P/E Ratio
  • CCEL $560.42
  • PYPD N/A
  • Revenue Growth
  • CCEL 2.33
  • PYPD N/A
  • 52 Week Low
  • CCEL $4.75
  • PYPD $2.30
  • 52 Week High
  • CCEL $9.43
  • PYPD $4.42
  • Technical
  • Relative Strength Index (RSI)
  • CCEL 45.67
  • PYPD 55.70
  • Support Level
  • CCEL $4.87
  • PYPD $3.34
  • Resistance Level
  • CCEL $6.35
  • PYPD $3.57
  • Average True Range (ATR)
  • CCEL 0.27
  • PYPD 0.16
  • MACD
  • CCEL -0.02
  • PYPD -0.04
  • Stochastic Oscillator
  • CCEL 8.11
  • PYPD 60.51

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

About PYPD PolyPid Ltd.

PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.

Share on Social Networks: